Skip to main content
. 2007 Dec 19;17(6):186–193. doi: 10.2188/jea.17.186

Table 4. Multiple linear regression on the associated factors related to the willingness-to-pay values of screening for diabetic retinopathy among type 2 diabetics in Kinmen.

Variables β SE 95% CI p-value
Intercept 586.49 117.92 354.18; 818.79 <0.0001
 
Sex (female vs male) 10.61 47.10 -82.18; 103.40 0.82
 
Age (60+ vs -59 yearrs) 41.00 22.87 -86.05; 74.06 0.07
 
Diabetic retinopathy
 Non-proliferative diabetic retinopathy vs no diabetic retinopathy 34.52 51.14 -66.24; 135.29 0.50
 Proliferative diabetic retinopathy vs no diabetic retinopathy 243.99 100.22 46.55; 441.44 0.02
 Legal blindness vs no diabetic retinopathy 420.06 112.78 197.88; 642.24 0.0002
 
Duration of type 2 diabetes (15; vs -14 years) -34.13 81.99 -195.66; 127.40 0.68
 
Education
 Junior high school or lower vs illiteracy 81.70 46.62 -9.68; 173.08 0.14
 Senior high school or higher vs illiteracy 113.89 53.66 8.72; 219.06 0.04
 
Income level (20,000+ vs -19,999 new Taiwan dollars/month) 53.77 60.73 -65.27; 172.80 0.09
 
Marriage (yes vs no+widow) -54.05 65.55 -183.19; 75.09 0.41
 
Body mass index (25+ vs -24 Kg/m2) 14.50 45.15 -74.45; 103.46 0.75
 
Total cholesterol (200+ vs -199 mg/dL) -111.24 55.67 -220.91; 15.74 0.18
 
Triglyceride (200+ vs -199 mg/dL) 80.23 54.76 -27.66; 188.12 0.14
 
Hemoglobin A1c (7+ vs -6.9 %) -73.40 46.41 -164.83; 18.03 0.12
 
Urine protein/Urine creatinine (0.2+ vs -0.19) 3.30 51.19 -100.55; 101.15 0.99
 
Medication (insulin injection vs oral hypoglycemic agents) 22.05 163.55 -300.15; 344.25 0.89
 
Other chronic diseases (2+ vs 0 or 1) 34.28 32.14 -97.60; 69.05 0.29

P-value of Komogorov-Smirnov test of normal distribution for WTP value =0.056

SE: standard error, CI: confidence interval